Furthermore, pDC-specific deletion of MHCII molecules also reduced the development of atherosclerosis via defective activation of antigen specific CD4+T cells, accompanied by a marked reduction of the T cell-produced inflammatory cytokine IFN-γ and T cell migration into the lesion (27). The gene discussed is CD4; the disease is atherosclerosis.